This site is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices.
Implementing Quality Initiatives is a team effort. The downloadable PDFs and presentations below help address implementation needs for practice administrators and pharmacists to lead the way in integrating QIs into your practice today.
The elements of the Quality Initiative described have not been validated or approved for securing accreditation or reimbursement, nor has the information been supported or endorsed by any entity for these purposes.
You play an important role in delivering quality care for patients with MPNs. Refer to this novel presentation to help you meet "The Evolving Need for Quality Care for Patients with Myeloproliferative Neoplasms," and for strategies on implementing Quality Initiatives.
View Slide DeckAssessing patients with MPNs symptom burden can be a challenge. This guide for pharmacy directors and clinical pharmacists can help you help your clinicians identify patients with burdensome disease-related symptoms to assist in improved MPN management.
Download PDFGet an overview of why Quality Initiatives for patients with myeloproliferative neoplasms are important, the steps in the process, and the types of MPN QIs to consider.
Download PDFRead this article to get Dr. John Winters’ perspective about why regular symptom assessment should be a key component of a QI for patients with MPNs. He offers practical insights for implementing a QI in your practice to improve quality of care.
Download PDFIn this article, Kellie Mozingo, Executive Director, Vita Medical Associates P.C., discusses why Quality Initiatives (QIs) for patients with MPNs are important to oncology practice managers. She shares how to determine which QI to implement, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) recommendations for assessing symptom burden, as well as tips for successful MPN QIs.
Download PDF